Risk-Benefit Comparisons Between Shorter and Longer Durations of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer-Reply

Colorectal Cancer
26/06/2020

Zaniboni A, et al. JAMA Oncol 2020.

NO ABSTRACT